ATTGENO AB
556692-7751ActiveDeveloping targeted nitric oxide delivery drugs for critical care applications.
Overview
- 1–4
- Employees
- ≤1K SEK
- Revenue
- 2005
- Founded
Description
Attgeno is a Swedish biotechnology company focused on saving patient lives through advanced drug delivery systems. Their core mission revolves around the targeted delivery of nitric oxide (NO), a vital molecule in various physiological processes. The company is pioneering the third generation of NO...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556692775101
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in FunnelfeedrCereno Scientific AB
10–19 employeesPioneering disease-modifying treatments for rare cardiovascular and pulmonary diseases.
LobSor Pharmaceuticals Aktiebolag
1–4 employeesDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
MucoLife Therapeutics AB
1–4 employeesDeveloping novel mucus modulators to treat COPD and Cystic Fibrosis.
Sangair AB
5–9 employeesDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Omnio Healer AB
0 employeesDeveloping regenerative plasminogen therapy to heal chronic wounds effectively.
Browse More
ATTGENO AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo